In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods. (July 2014)
- Record Type:
- Journal Article
- Title:
- In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods. (July 2014)
- Main Title:
- In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods
- Authors:
- Meng, Jia
Li, Song
Yao, Qing
Zhang, Ling
Weng, Yan
Cai, Cuifang
Xu, Hui
Tang, Xing - Abstract:
- <abstract> <title>Abstract</title> <p>In order to improve the <italic><italic>in vitro</italic></italic> dissolution rate and <italic><italic>in vivo</italic></italic> oral bioavailability of the poorly water soluble drug, felodipine (FELO), the wet-milling process was employed involving co-grinding with HPMC E5 and the <italic>in vitro</italic> release rate as investigated. After solidification by spray drying or freeze drying, the microsized powders were characterized in terms of their size, morphology, and <italic>in vitro</italic> dissolution rate. The oral bioavailability of this dry powder for suspension was evaluated in rats. After milling with 8% HPMC E5 and freeze drying, the powder mixture had an average particle size of 2.249 ± 1.497 μm and displayed an excellent dissolution rate of up to 93.2% within 10 minutes. DSC and PXRD investigations confirmed the absence of any crystal transformation during the wet-milling process. Using two different solidification methods, powders were stable for 6 months with regard to their <italic>in vitro</italic> dissolution rate. Significantly improved bioavailability was obtained for the wet-milled suspension before solidification and freeze dried powders with 6.8- (<italic>p</italic> &lt; 0.001) and 3.6-fold (<italic>p</italic> &lt; 0.01) increases, respectively, compared with that of the un-milled FELO. Also, no marked difference (<italic>p</italic> &gt; 0.05) in bioavailability was seen for the spray dried powders. These<abstract> <title>Abstract</title> <p>In order to improve the <italic><italic>in vitro</italic></italic> dissolution rate and <italic><italic>in vivo</italic></italic> oral bioavailability of the poorly water soluble drug, felodipine (FELO), the wet-milling process was employed involving co-grinding with HPMC E5 and the <italic>in vitro</italic> release rate as investigated. After solidification by spray drying or freeze drying, the microsized powders were characterized in terms of their size, morphology, and <italic>in vitro</italic> dissolution rate. The oral bioavailability of this dry powder for suspension was evaluated in rats. After milling with 8% HPMC E5 and freeze drying, the powder mixture had an average particle size of 2.249 ± 1.497 μm and displayed an excellent dissolution rate of up to 93.2% within 10 minutes. DSC and PXRD investigations confirmed the absence of any crystal transformation during the wet-milling process. Using two different solidification methods, powders were stable for 6 months with regard to their <italic>in vitro</italic> dissolution rate. Significantly improved bioavailability was obtained for the wet-milled suspension before solidification and freeze dried powders with 6.8- (<italic>p</italic> &lt; 0.001) and 3.6-fold (<italic>p</italic> &lt; 0.01) increases, respectively, compared with that of the un-milled FELO. Also, no marked difference (<italic>p</italic> &gt; 0.05) in bioavailability was seen for the spray dried powders. These effects suggest that the solidification method plays an important role in modifying the bioavailability of FELO after wet milling. Consequently, wet-milling is an effective technique to enhance the bioavailability of FELO and to maintain these benefits, freeze-drying is a feasible approach to solidifying the wet-milled suspension for industrial applications.</p> </abstract> … (more)
- Is Part Of:
- Drug development and industrial pharmacy. Volume 40:Number 7(2014:Jul.)
- Journal:
- Drug development and industrial pharmacy
- Issue:
- Volume 40:Number 7(2014:Jul.)
- Issue Display:
- Volume 40, Issue 7 (2014)
- Year:
- 2014
- Volume:
- 40
- Issue:
- 7
- Issue Sort Value:
- 2014-0040-0007-0000
- Page Start:
- 929
- Page End:
- 936
- Publication Date:
- 2014-07
- Subjects:
- Pharmaceutical chemistry -- Periodicals
Pharmaceutical industry -- Periodicals
Drug Industry -- Periodicals
Technology, Pharmaceutical -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/ddi ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/03639045.2013.790409 ↗
- Languages:
- English
- ISSNs:
- 0363-9045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.116000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3232.xml